Dow Down 0.32% Nasdaq Down 0.62%

Myriad Genetics, Inc. (MYGN)

-NasdaqGS
36.00 Down 1.15(3.10%) Apr 29, 4:00PM EDT
|After Hours : 36.00 0.00 (0.00%) Apr 29, 4:55PM EDT
Prev Close:37.15
Open:36.89
Bid:32.94 x 100
Ask:39.09 x 100
1y Target Est:41.25
Beta:0.229827
Next Earnings Date: 3-May-16MYGN Earnings announcement
Day's Range:35.63 - 37.06
52wk Range:30.30 - 46.24
Volume:603,482
Avg Vol (3m):947,383
Market Cap:2.57B
P/E (ttm):27.07
EPS (ttm):1.33
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for MYGN

Comparison

Symbol% ChgMkt Cap
MYGNDown 3.10%2.57B
ABTDown 3.76%57.31B

Key Statistics

Forward P/E (1 yr):19.57
P/S (ttm):3.54
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Jun-16) :1.66
Quarterly EPS Est (Mar-16) :0.38
Mean Recommendation*:2.5
PEG Ratio (5 yr expected):1.42

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Myriad Genetics, Inc., a personalized medicine company, focuses on the development and marketing of predictive, personalized, and prognostic medicine tests worldwide. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback